Key points are not available for this paper at this time.
Background: Highly active antiretroviral therapy (HAART) program requires adequate monitoring of the potential adverse events to the antiretroviral (ARV) drugs. We investigated the ARV drug combinations prescribed for HIV-infected children and their suspected adverse events.
Kazeem A. Oshikoya (Sun,) studied this question.